The antifungal and antibacterial properties of the crude extract from Streptomyces sp. (strain Go40/10) encouraged us to perform a detailed analysis of its secondary metabolite pattern by chemical screening, which revealed the presence of at least 30 different compounds. Ten of the isolated 1 8 metabolites proved to be new. Remarkable are hydrogenated (3, 4) and glucosylated (5, 6, 7) 14-membered macrolides derived from cineromycin B, two /-butyrolactones (8, 9), the so far unknown naphthomycin K (14) and the collinolactones A and B. The constitution and relative stereochemistry of these metabolites were deduced from spectroscopic data. Finally the concept of our one strain/many compounds (OSMAC) method for exploring new microbial secondary metabolites is discussed.
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In our chemical screening program2) we discovered Streptomyces sp. Go 40/10, which exhibited antifimgal (Mucor hiemalis, Candida albicans) and antibacterial (Bacillus subtilis) activity together with an unusual extensive secondary metabolite pattern. By HPTLCanalysis at least 30 compounds were detected utilizing their color, UVabsorbtion (254 and 366 nm) and/or colorization reactions.
Applying the OSMAC (one strain/many compounds) method3?4) to strain Go 40/10 we isolated 18 metabolites in yields of 0.1 to 22.0mg/liter. These metabolites belong to four different chemical classes: 14-membered macrolides, y-butyrolactones, ansamycins and the collinolactones, new polyketides with a tricyclic cyclodecatriene core1}.
The present paper deals with the purification procedures leading to the various secondary metabolites, their physicochemical properties and structural elucidation studies. The collinolactones are part of a prior publication!).
Fermentation and Isolation
Fermentation of Streptomyces sp. (strain Go 40/10) was carried out in a soybean meal/mannitol medium at 28°C by using different culture vessels and aeration conditions, which all yields the same product pattern with little varia-tion in the relative amounts of the individual secondary metabolites. On the basis of TLCanalysis, time for harvesting was fixed at 72 hours of fermentation. The interesting metabolites were found mainly in the culture filtrate, only the antifungal ansatrienins were isolated from the mycelium extract (acetone). The culture filtrate was separated from the mycelium by filtration and worked up according to Scheme 1. The observed biological activity of the raw extracts could be assigned to the already known components of the mixture5 '1 1?14) .
Cineromycins
The 14-membered macrolides were detected by HPTLC as two distinct groups showing similar Rf values and colorization reactions within each of them ( Table 1 ). The more lipophilic metabolites (Rf 0.25-0.57, CHCl3 -MeOH, 9 : 1, violet spots) were identified as cineromycin B (1)5~7) and hydrogenated derivatives of it, the hydrophilic group (Rf 0.08-0.09, CHCl3-MeOH, 9 : 1, red spots) comprise three glucosylated cineromycins. The derivatives of 1 with higher Rf values (Table 1) Hz between 7-H and 8-H we assume a cis conformation of the two protons, this results in the shown R configuration of C-8. Furthermore the known 7-dehydrocineromycin B6'7) could be isolated in small amounts.
The three members of the more hydrophilic cineromycin B derivatives showed a very similar chromatographic behavior. The application of strong separating steps was limited, because of the instability of the compounds. The structure elucidation of the most hydrophilic compound, 7-0-(a-glucosyl)-cineromycin B (5) was done with a sample of 80% purity. The FAB-MS (474, [M+NH3+H+]) suggested a molecular weight of 456 in agreement with an addition of a hexose moiety to 1. This was supported by the *H NMRspectrum, which in comparison to 1 showed additional signals between <5=3-5 belonging to an a-glucosyl spin system as was revealed by the 37r_H_2._H coupling constant of 4.0Hz and a COSYexperiment. The connection between the glucosyl residue and the aglycon was established by the down field shift of C-79) in comparison 637 to 1 (5: 5C_7=78.7; 1: <5C_7=75.5) and the chemical shift of the anomeric carbon atom (<5C=96.6), leading to the structure depicted for 5.
The second compound was identified as the new 1-0-(a-glucosyl)-2,3-dihydrocineromycin B (6). The structure was verified by DCI-MS (481, [M+Na+] ) and NMR. The only difference between 5 and 6 was the lack of signals of the C-2/C-3 double bond in the NMRspectra and the presence of two additional methylene groups. The point of attachment of the sugar moiety could be unambiguously determined by the down field shift of C-7 (AS=+6.2ppm) and HMBC correlations between both, C-7/1 '-H and C-l 77-H. The third member of this group, 7-(9-(a-glucosyl)-5,6dihydrocineromycin B (7), was the most unstable one and already disintegrated after the *H NMRexperiment. Comparison of this spectrum with that of 5 revealed the absence of the C-5/C-6 double bond and the presence of two additional methylene groups. This result in combination with two fully elucidated glucosylated cineromycin B derivatives leads to the proposal of structure 7 despite the incomplete data.
y-Butyrolactones
The HREI-MS of lactone I (8) (ra/z=228) indicates the empirical formula CnH16O5. The 13C NMR spectrum includes signals of eleven C-atoms: one methyl and two methylene groups, two aliphatic and four olefinic methine carbon atoms as well as one carbonyl group and a quarternary carbon atom (5=79.1), which is attached to an oxygen as it is the case for the methylene and one methine group. In the *H NMRspectrum in DMSO-<i6 all of the 16 predicted hydrogen atoms are visible. An analysis Lactone II (9) shows a molecular ion at m/z=242, which led to the molecular formula CnH14O6(HREI-MS). The 13C NMRspectrum reflects the high degree of oxygenation due to the presence of five signals between <5c=8Oand 55, two of them at <5C=55.5 and 55.2 could be assigned to an epoxide. The chemical shifts of two olefinic protons at Sc= 124.2 (C-7) and 143.4 (C-8) together with the signal at Sc= 165.1 (C-6) indicated the presence of an a,/?-unsaturated ester. Further^H-and^-^C-shift correlation NMR spectra allows us to establish the constitution of a dihydro-4-[4,5-epoxy-l -oxohex-2-enyloxy-methyl]-3-hydroxy- [M+H]+), while comparison of the lH NMRdata presented the lack of a methyl group as well as additional signals ofa hydroxymethylene group (<5H=3.68/3.63), whose 13C NMR (5C=64) fits well. Thus the structure is as depicted for 14 ( Fig.  3) . VOL.52 NO.7 THE JOURNAL OF ANTIBIOTICS
Discussion
Detailed investigation of the secondary metabolite pattern of strain Streptomyces sp. Go 40/10 leads to the isolation and structure elucidation of 1 8 compounds, ten of them not described in the literature before. The compounds 5, 6 and 7 represents the first glycosylated macrolides of the cineromycin B-type. Unfortunately, unlike the structurally related erythromycin A or oleandomycin15) these metabolites exhibit no antibacterial activity. Nevertheless, together with the new hydrogenated derivatives 3 and 4 they allow us to complete the picture of structural variability of the cineromycin B class: Oxidation/methylation/glucosylation at C-7, oxygenation of 8-Me and saturation of all three double bonds are possi-ble6'7>.
The new y-butyrolactone 8 is structurally related to A-factor16), the virginiae butanolides17) and especially butalactin (10)18), which also carries an hydroxyl group at C-2. Another mutuality of 8, 9 and 10 is their inability to stimulate aerial mycelium formation of Streptomycetes. It is reasonable to assume a virginiae butanolide-like biosynthesis for 8, which utilizes a tetraketide moietyI9). In contrast to 8 the structure of lactone II (9) shows similarities to the musacins Bj/B27), the lactonization of which follows a different mode than described for the A-factor analogues. Naphthomycin K(14) is the first representative of the naphthomycin B series (characterized by the ZIEIZ configuration of the triene moiety), which is modified in the ansa chain. So far this biosynthetic feature was observed in the rifamycin class only, where the corresponding methyl group (C-28 Me) in proansamycin B-M is eliminated by successively oxidation via the alcohol (rifamycin W), the aldehyde and the carboxylic acid, followed by decarboxylation (rifamycin S)20). Since chloroansamycins like ll can be converted to thioansamycins like 13 with thiols in vitro2l\ it is reasonable to assume that this conversion is nonenzymatic.
An analysis of the polyketide chains of the isolated metabolites revealed the fact, that strain Go 40/10 must harbour at least six different polyketide synthases of type I, which are used in parallel and lead to six different core structures: Ansatrienins, naphthalene ansamycins, cineromycins, two types of 7-butytolactones and collinolactones. It seems to be a general characteristic of Streptomycetes to contain a complete gene cluster for each different carbon skeleton of the secondary metabolites they 639 synthesize. The combination of cineromycins and musacinlike compoundsis reminiscent of Streptomyces griseoviridis (strain FH-S 1832)7), whereas the commonoccurrence of ansamycin antibiotics and collinolactones is the same as in Streptomyces collinus (strain Tii 1892)22). A comparative TLCanalysis of extracts of the latter and of Go 40/10 revealed the more lipophilic cineromycins and the 7-butyrolactones as congeners as well, but in very small amounts only. Weassume that in some cases gene clusters can occur concurrently in the genomeindependent of other features of a given strain and that the overall number of such secondary metabolism gene clusters in a given genome is much higher than estimated up to now.
Analyzing the secondary metabolite pattern of Go 40/1 0, we illustrated that the application of the OSMAC-method3'4) is valuable for exploring the potential of different gene clusters and attaining both, new derivatives of known classes of compounds as well as novel structures. This demonstrates that it is worthwhile to investigate carefully selected strains of a family of established producers of secondary metabolites. Based on the finding that more than 50% of the isolated compounds from Go 40/10 proved to be new,the combination of chemical screening for selecting suitable strains and the OSMAC-methodfor exploring their biosynthetic potential to the fullest, is a very successful strategy for finding novel secondary metabolites and for getting more information about the occurrence and the regulation of secondary metabolites, biosynthesis genes and enzymes. Table 1 ); [a]á" -60 (c 0.005, CHC13); UV /L^aex0H nm (e) 201 (1794), 226 (567); MP 88-90°C; IR (KBr) cm"1 3410 (br), 2931 , 2874 , 1701 , 1458 , 1211 , 1108 , 1072 lRNMR(500MHz, CDC13) 1.90 (dd4 7=14.0, 9.5, 4 .0Hz, 1H, 3-Hb), 1.99 (m, 1H, 2.21 (m, 2H, 2.41 (dd4 7=16.0, 9.5, 4.0Hz, 1H, 3.29 (dd, 7=9.0, 9.0Hz, 1H, 3.38 (dd, 7=9.5, 4.0Hz, 1H, 3.58 (dd4 7=9.0, 5.0, 2.5Hz, 1H, 3.65 (dd, 7=9.5, 9. 0Hz, 1H, 3' -H), 3.66 Table 2 . C NMRdata of the new cineromycin B derivatives 3 to 6. 
